Oral Antibiotics for Treating Children With Community-Acquired Pneumonia Complicated by Empyema

Clin Pediatr (Phila). 2019 Nov;58(13):1401-1408. doi: 10.1177/0009922819850494. Epub 2019 May 23.

Abstract

No consensus exists on management of children with community-acquired pneumonia complicated by empyema (CAP-Em). We evaluated outpatient oral (O-Abx) compared with parenteral antibiotics (OPAT) in children with CAP-Em. We also evaluated inflammatory markers to guide length of treatment. We conducted a retrospective cohort study of patients discharged (2006-2016) with CAP-Em. Primary outcome measured was treatment success (no change in antibiotics or readmission to hospital for treatment of CAP-Em). White blood cell (WBC) count, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) serial measurements were identified. Success was achieved in 133/144 (92.4%) O-Abx and 7/12 (58%) OPAT patients (P = .0031). WBC and CRP decreased early; and ESR increased initially (admit and switch to O-Abx) and decreased by end of treatment. O-Abx is the modality of choice for treatment of CAP-Em after hospital discharge. WBC and CRP are useful to monitor success of O-Abx switch; and ESR provides guidance for length of treatment.

Keywords: Streptococcus pneumoniae; community-acquired pneumonia; empyema.

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Biomarkers / blood
  • Child
  • Child, Preschool
  • Cohort Studies
  • Community-Acquired Infections / blood
  • Community-Acquired Infections / complications*
  • Community-Acquired Infections / drug therapy*
  • Empyema / blood
  • Empyema / drug therapy
  • Empyema / etiology*
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Infant
  • Male
  • Pneumonia / blood
  • Pneumonia / complications*
  • Pneumonia / drug therapy*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Biomarkers